BioMed Research International

BioMed Research International / 2015 / Article
Special Issue

Epidemiology, Detection, and Control of Foodborne Microbial Pathogens

View this Special Issue

Research Article | Open Access

Volume 2015 |Article ID 191409 |

Jaime Ariza-Miguel, María Isabel Fernández-Natal, Francisco Soriano, Marta Hernández, Beatrix Stessl, David Rodríguez-Lázaro, "Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006–2014", BioMed Research International, vol. 2015, Article ID 191409, 10 pages, 2015.

Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006–2014

Academic Editor: Milton O. Moraes
Received18 Apr 2015
Revised23 Jun 2015
Accepted01 Jul 2015
Published11 Oct 2015


We investigated the pathogenicity, invasiveness, and genetic relatedness of 17 clinical Listeria monocytogenes stains isolated over a period of nine years (2006–2014). All isolates were phenotypically characterised and growth patterns were determined. The antimicrobial susceptibility of L. monocytogenes isolates was determined in E-tests. Invasion assays were performed with epithelial HeLa cells. Finally, L. monocytogenes isolates were subtyped by PFGE and MLST. All isolates had similar phenotypic characteristics (β-haemolysis and lecithinase activity), and three types of growth curve were observed. Bacterial recovery rates after invasion assays ranged from 0.09% to 7.26% (1.62 ± 0.46). MLST identified 11 sequence types (STs), and 14 PFGE profiles were obtained, indicating a high degree of genetic diversity. Genetic studies unequivocally revealed the occurrence of one outbreak of listeriosis in humans that had not previously been reported. This outbreak occurred in October 2009 and affected three patients from neighbouring towns. In conclusion, the molecular epidemiological analysis clearly revealed a cluster (three human cases, all ST1) of not previously reported listeriosis cases in northwestern Spain. Our findings indicate that molecular subtyping, in combination with epidemiological case analysis, is essential and should be implemented in routine diagnosis, to improve the tracing of the sources of outbreaks.

1. Introduction

Listeria monocytogenes is an emerging foodborne pathogen capable of infecting animals and humans. It is the leading cause of death in reported cases of food poisoning [1]. The groups at highest risk of listeriosis are pregnant women, in whom this infection may cause late miscarriage or stillbirth, neonates, immunocompromised individuals, and the elderly, in whom it causes mostly septicaemia and meningoencephalitis [2, 3]. The incidence of listeriosis has recently been reported to be higher among the elderly than in other groups [4, 5]. The case-fatality rate is still increasing (20–30%) worldwide, despite antibiotic treatment [6, 7]. Noninvasive listeriosis is often associated with febrile gastroenteritis and sometimes with cutaneous forms, as observed in veterinary surgeons coming into direct contact with aborted foetuses from livestock [8, 9]. The disease is usually vertically transmitted during pregnancy or acquired by the consumption of contaminated food, particularly fresh and ready-to-eat products that are not heated before consumption [10, 11]. A European Food Safety Authority (EFSA) baseline study focusing on ready-to-eat (RTE) food indicated that smoked and marinated fish products carried the highest risk of L. monocytogenes contamination [1]. In the US, poultry meat was found to be responsible for most (63%) fatal cases of listeriosis [12]. A recent study showed that foodborne outbreaks in hospitalised patients on immunosuppression treatments were linked to hospital food (e.g., sandwiches and celery) [5].

L. monocytogenes consists of four discrete evolutionary lineages (I–IV) and 13 serotypes [13, 14]. Historically, diverse molecular typing methods, including PFGE, multilocus enzyme electrophoresis, and ribotyping, have been used to study the genetic diversity of the isolates involved in international outbreaks. Thus, epidemic clones (ECs) involved in geographically and temporally distant outbreaks or in large, single outbreaks have been defined [15]. In the last decade, ECs have been redefined on the basis of multi-virulence-locus sequence typing (MVLST), which is based on the analysis of six to eight genes [16]. Multilocus sequence typing (MLST), which is based on the analysis of seven housekeeping genes [17], has also been used for the definition of clonal groups. Sequence types (ST) are defined as a unique combination of MLST allele designations used in the MLST scheme, and clonal complexes (CC) are defined as groups of STs differing by only one housekeeping gene from other members of the group. An analysis of L. monocytogenes isolates from five continents by MLST demonstrated the existence of globally successful genetic groups [18]. Seven “epidemic clones” (ECs) have been defined by MVLST, each descended from a common ancestor with a similar temporal and spatial virulence profile [16, 17, 19, 20]. ECI, corresponding to the CC1 identified by MLST, and ECIV (CC2) appear to be cosmopolitan clones involved in many outbreaks [16]. L. monocytogenes sequence type (ST) 6 (ECII) has been implicated in human meningitis with a fatal outcome [21]. L. monocytogenes serogroups most frequently associated with clinical cases are serotype 4b, followed by 1/2b (genetic lineages I and III), and 1/2a (genetic lineage II) [14]. L. monocytogenes serotype 1/2a is increasingly being isolated from cases of invasive listeriosis in Italy and Switzerland [2124]. A link between isolates obtained from patients and isolates obtained from smoked fish has been reported in Scandinavian countries (Sweden, Norway, and Finland) and in eastern Spain [2529]. Furthermore, actual outbreaks of listeriosis have been linked to L. monocytogenes serotype 1/2a and seem to be particularly prevalent in cheese processing plants [10, 3033].

The incidence of listeriosis in Spain has increased steadily over the last decade. There were a reported 0.56 cases per 100,000 inhabitants from 2001 to 2007 [34]. Martínez et al. [35] reported 0.67 invasive listeriosis cases per 100,000 inhabitants in Valencia during the 2008–2010 period. In 2012, the notification rate for listeriosis cases in Spain was the second highest of any member state of the EU (0.93, versus an EU-wide rate of 0.41 per 100,000 inhabitants) [6].

Mortality rates are high for invasive listeriosis, justifying the use of combinations of molecular subtyping tools for the identification of clusters associated with outbreaks, tracing the source of the outbreak, and preventing further transmission. These methods were therefore combined in a retrospective study focusing on invasive listeriosis cases in León (2006–2014) and involving in vitro virulence testing.

2. Materials and Methods

2.1. Case Definition

All patients suffering from meningitis, bacteraemia, or infection during pregnancy were considered as potential cases of listeriosis. The infection was confirmed by the isolation of L. monocytogenes from a normally sterile site.

2.2. Description of the Hospital

The study has been carried out in the “Complejo Asistencial Universitario de León” (CAULE), a facility with about 800 beds located in the province of León in Northwest Spain. It serves an urban population of over 130,000 inhabitants and the total population of the metropolitan area has been estimated at over 490,000.

2.3. Clinical Cases

In total, there were 17 clinical cases of listeriosis at the CAULE from 2006 to 2014. These cases occurred in one premature newborn and 11 male and five female patients, aged from 31 to 89 years. In total, 11 L. monocytogenes isolates were recovered from blood cultures, and six were recovered from cerebrospinal fluid (CSF). In some patients L. monocytogenes isolates were recovered from both blood cultures and CSF () or from peritoneal fluid (PF; ) or synovial joint fluid (JF; ) (Table 1).

SampleSexAgeDateSourceClinical diagnosisAntibiotic treatmentProvincePFGE pulsotypeMLST ST

Genetic lineages I and III
1M60Jun. 06CSFMeningoencephalitisAmpicillinLeónH1
8M44Oct. 09CSFMeningoencephalitisAmpicillin/gentamicinLeónD1
9F68Oct. 09Blood culture/CSFMeningoencephalitis/sepsisAmpicillin/gentamicin/vancomycinLeónD1
10MNBOct. 09Blood cultureSepsisAmpicillin/gentamicinZamoraD1
7M76Feb. 09Blood culture/JFArthritis/bacteraemiaAmpicillin/gentamicinLeónG2
6M83Jan. 09Blood cultureBacteraemiaAmpicillin/gentamicinLeónE3
11M50Feb. 10Blood cultureSepsisAmpicillin/gentamicinAsturiasA3
15M82Jul. 13CSFMeningoencephalitisAmpicillin/gentamicinLeónL4
13F89Feb. 12Blood cultureSepsisAmpicillin/gentamicinLeónB87
4F31Apr. 07Blood cultureFever in pregnant womanAmoxicillin clavulanateLeónF389

Genetic lineage II
5M50Dec. 08CSFMeningoencephalitisAmpicillin/gentamicinLeónK9
2M84Sep. 06Blood culture/PFPeritonitis/sepsisAmpicillin/vancomycinLeónI16
3M40Feb. 07CSFMeningoencephalitisAmpicillin/gentamicinLeónI16
12M65Apr. 10Blood cultureSepsisAmpicillin/gentamicinLeónJ16
14F82Jun. 12Blood cultureSepsisAmpicillin/gentamicinLeónC399
16M59Feb. 14CSFMeningoencephalitisAmpicillin/gentamicinLeónM7
17F63Feb. 14Blood culture/CSFMeningoencephalitis/sepsisAmpicillin/gentamicinLeónN8

Foetal death. Full recovery of the mother; Deceased.
PFGE, pulsed-field gel electrophoresis; MLST, multilocus sequence typing; NB, premature newborn; CSF, cerebrospinal fluid: JF, joint fluid; PF, peritoneal fluid.
2.4. Isolation and Confirmation of L. monocytogenes

Clinical isolates of L. monocytogenes were streaked onto two selective chromogenic agar plates: ALOA (Agar Listeria Ottaviani & Agosti) medium (CHEMUNEX, Bruz Cedex, France) and RAPID L. mono agar (Bio-Rad Laboratories, Inc., Hercules, Ca, US). The bacteria were subjected to Gram staining and catalase and Christie Atkins Munch-Petersen (CAMP) tests. The collection strain S. aureus CECT 828 was used in the CAMP test, as recommended, to enhance L. monocytogenes haemolysis.

Each of the L. monocytogenes isolates was confirmed biochemically (API Coryne V.2.0; bioMérieux, Marcy l’Etoile, France) and by real-time PCR methods for differentiating between Listeria species [3639]. The L. innocua CECT910, L. monocytogenes ITA1315, and L. ivanovii ATCC19119 reference strains served as positive controls in the PCR assays.

2.5. L. monocytogenes Growth Curves

Growth curves were determined by culture in brain heart infusion (BHI, Oxoid, Hampshire, UK), with the measurement of optical density at 600 nm in a Lambda 35 UV/VIS Spectrometer (PerkinElmer, Massachusetts, USA) over a 24-hour period of incubation at 37°C, with shaking at 180 rpm.

2.6. Antimicrobial Susceptibility Testing

The susceptibility of 17 clinical L. monocytogenes isolates to 16 antimicrobial agents was determined by E-tests on Mueller-Hinton agar supplemented with 5% sheep’s blood, incubated under an atmosphere of ambient air at 35°C, with reading of the plates after 20–24 h. Susceptibility to antibiotics was interpreted applying the recommendations of the EUCAST for the antimicrobial susceptibility of L. monocytogenes [40]. The following antibiotics were tested: benzylpenicillin, ampicillin, imipenem, meropenem, erythromycin, clindamycin, gentamicin, vancomycin, daptomycin, linezolid, ciprofloxacin, moxifloxacin, tetracycline, tigecycline, rifampin, and cotrimoxazole.

2.7. Invasion Assays

We assessed the invasiveness of 17 clinical L. monocytogenes isolates in an epithelial HeLa cell culture assay, as previously described [41]. A well characterised clinical L. monocytogenes serovar 4b strain (P14) and its isogenic prfA gene deletion mutant (ΔprfA) were included in the assay as controls. HeLa ATCC CCL-2 cells were maintained at 37°C, under an atmosphere containing 5% CO2. The invasiveness of each L. monocytogenes isolate was analysed in quadruplicate (2 independent invasion assays, with each isolate analysed in duplicate in each assay). Between passages 1 and 14, cell lines were maintained in Eagle’s minimum essential medium (MEM; Gibco, San Diego, United States) supplemented with 2 mM L-glutamine, 10% foetal bovine serum, and 1% nonessential amino acids. Bacteria were resuspended in plain Eagle’s minimum essential medium and used to infect HeLa cells at a multiplicity of infection (MOI) of 20 : 1, with the exception of the ΔprfA mutant strain of L. monocytogenes, for which we used a MOI of 200 : 1.

2.8. Molecular Epidemiological Analysis

L. monocytogenes serogroups were defined according to a multiplex PCR targeting the specific target genes lmo0737, lmo1118, ORF2819, ORF2110, and Listeria spp.-specific prs published by Doumith et al. [42] and amended by Leclercq et al. [43] for PCR IVb-VI. L. monocytogenes clinical isolates were genomically characterised by pulsed-field gel electrophoresis (PFGE) with the restriction enzymes ApaI and AscI, according to the standardised international protocol of PulseNet [44]. We analysed PFGE profiles with Bionumerics v.6.6 software (Applied-Maths NV, Sint-Martens-Latem, Belgium), to describe the genetic relationships between isolates. Dendrograms were constructed with the Dice similarity coefficient and the unweighted pair group mathematical average (UPGMA) clustering algorithm. Tolerance and optimisation values were set to 1.5%, in accordance with the recommendations of Martin et al. [45]. Simpson’s index of diversity, which measures the probability of two unrelated strains sampled from the test population being placed in different typing groups [46], was calculated to compare the discriminative power of PFGE, via a website comparing partitions [47]. Fingerprints were interpreted according to the recommendations for foodborne pathogens [48]. Multilocus sequence typing (MLST) was performed as described by Ragon et al. [17]. Allele types were assigned for seven housekeeping loci, abcZ (ABC transporter), bglA (beta glucosidase), cat (catalase), dapE (succinyl diaminopimelate desuccinylase), dat (D-amino acid aminotransferase), ldh (L-lactate dehydrogenase), and lhkA (histidine kinase), and the resulting sequence types (STs) were determined and compared, with the Institute Pasteur Listeria monocytogenes MLST database [49]. Sequence types (STs) were defined as a unique combination of MLST allele designations used in the MLST scheme, and clonal complexes (CC) were defined as groups of STs differing by only one housekeeping gene from other members of the group [17]. An allelic profile-based comparison, based on the use of a minimum spanning tree (MST) and the Pasteur Institute online tool, was performed to define the relationships between strains at the microevolutionary level.

2.9. Statistical Analysis

Statistical two-way analysis of variance (ANOVA) was used to evaluate differences in invasive capacity between isolates, based on the 95% confidence interval and Bonferroni multiple comparison tests to assess the differences in greater depth (GraphPad Prism v.5.0). The threshold value for this test was set at 0.05.

3. Results

3.1. Patient Outcomes

The outcome was favourable after antibiotic treatment in 15 of the 17 patients. Progression was observed in case 4, a pregnant woman whose foetus died as a result of the infection. Patient 9 died after antibiotic treatment failure. Further information is provided in Table 1.

3.2. L. monocytogenes Isolation, Confirmation, and Growth Curves

All 17 clinical isolates were confirmed to be L. monocytogenes by phenotypic and genetic methods. β-haemolytic and lecithinase activities, at 24, 48, and 72 hours, were similar in all the clinical isolates. As expected, these activities were stronger in L. ivanovii ATCC19119, and L. innocua CECT910 displayed no activity. The isolates recovered from clinical cases 6 and 7 had specific growth patterns (GPs), reaching the exponential growth phase later than the other isolates (exponential growth phase from 5 to 12 hours and from 13 to 23 hours of incubation, resp.). The exponential phase in the other L. monocytogenes isolates began after about three hours and continued until about 6.5 hours of incubation. Representative growth curves for the isolates are shown in Figure 1.

3.3. Antimicrobial Susceptibility Testing

The antimicrobial susceptibility data for the 17 isolates tested are presented in Table 2. In the E-test method, all our isolates were found to be susceptible to benzylpenicillin, ampicillin, erythromycin, and cotrimoxazole. In 10 isolates, the MIC of meropenem was 0.38 to 0.75 mg/L. These isolates may be considered resistant, according to the strict criterion of the EUCAST susceptibility breakpoint. No susceptibility breakpoints have been identified for the other 11 antibiotics by EUCAST, and the MICs of these antibiotics ranged between 0.125 and 4 mg/L.

AntibioticMIC (mg/L)Susceptibility breakpoint (mg/L)% susceptibility


According to EUCAST antimicrobial susceptibility breakpoints for L. monocytogenes.
3.4. Invasion Assays

All clinical isolates of L. monocytogenes were tested in invasion assays with HeLa epithelial cells. The actual mean MOI used for cell infection with the clinical isolates was 17 : 1 (standard error: 0.83). The recovery rates for clinical isolates ranged from 0.09% to 7.26% (median: 1.62, standard error: 0.46). As expected, the recovery rate for the noninvasive ΔprfA mutant strain was very low (0.13%, standard error: 0.04). Invasiveness was between 0.04 and 3.1 times higher than that of the L. monocytogenes serovar 4b clinical control strain (P14) (Figure 2). The isolates clustered into two significantly different groups: those with a high invasion rate similar to that of the wild-type strain P14 () (isolates from clinical cases 1, 8, 9, 12, 14, and 15) and isolates with a low invasion rate, similar to that of the isotypic ΔprfA strain () (isolates from clinical cases 2, 3, 4, 5, 6, 7, 10, 11, 13, 16, and 17 (Figure 2)).

3.5. Molecular Epidemiological Analysis

Genetic characterisation by PFGE with the restriction enzyme ApaI revealed 13 different pulsotypes, and characterisation with AscI discriminated between 14 genotypes (Simpson’s index of diversity values of 0.949 and 0.971, resp.). Fingerprinting revealed the presence of 8–20 DNA fragments between about 40 and 560 kb in size. PFGE analyses combining the results obtained with both restriction enzymes identified 14 unique pulsotypes, resulting in a Simpson’s index of diversity of 0.971. The clinical isolates displayed 55% similarity and formed three clusters, arbitrarily designated A to C. Cluster A contained six isolates recovered from 2006 to 2014 (58% similarity). Cluster B contained eight isolates recovered from 2006 to 2013 (66% similarity). Cluster C consisted of three isolates (68% similarity) collected from 2010 to 2012. Interestingly, the isolates from clinical cases 8, 9, and 10 on one hand and those from cases 2 and 3 on the other hand had indistinguishable pulsotypes (pulsotypes D and I, resp.). The genetic relationships between L. monocytogenes isolates, based on the combined PFGE-genetic profiles obtained with the restriction enzymes ApaI and AscI, are shown in Figure 3.

MLST analysis of 17 L. monocytogenes isolates from clinical cases of listeriosis identified 11 STs (Simpson’s index of diversity: 0.926). The oldest and globally most prevalent epidemic clones (ST1, ST2, ST3, ST4, ST7, ST8, and ST9) were represented among the STs of the clinical cases observed in the Spanish regions of León, Asturias, and Zamora in 2006–2014 (Table 1; Figures 4(a) and 4(b)). Ten isolates (58.8%) were assigned to genetic lineage I or III. Four of these isolates were ST1 isolates (3 with PFGE profile D and 1 with PFGE profile H) recovered from human patients from the neighbouring provinces of León and Zamora during 2006 and 2009. ST3 isolates were obtained from two patients from the provinces of León and Asturias in 2009 and 2010, respectively. These cases were not related and the isolates concerned had different PGFE profiles (A and E). Furthermore, ST2, ST4, ST87, and ST389 were sporadically observed, in one isolate each. The L. monocytogenes isolates from genetic lineages II (; 41.2%) were more evenly distributed in the MST. The most common allelic profile was ST16 (; 17.6%). ST7, ST8, ST9, and ST399 were observed sporadically, in one isolate each (Table 1).

4. Discussion

Most of the reported cases of listeriosis occur in high-income countries, this infection being largely underreported in developing countries. Hospitalisation records show listeriosis to be the third most costly zoonotic disease in the US [34, 50]. Patients often suffer from comorbid diseases and are immunocompromised, and long-term antibiotic treatment with ampicillin, amoxicillin, and gentamicin may be required. Some L. monocytogenes strains can survive treatment with cephalosporin or erythromycin [51]. Livestock and processed foods seem to serve as a source of antibiotic resistance. Some authors have reported increases in the frequency of multidrug-resistant strains (e.g., resistant to amoxicillin-clavulanate and chloramphenicol) [25, 52]. No resistance to benzylpenicillin, ampicillin, erythromycin, or cotrimoxazole was found in our isolates. Remarkably, 10 isolates were classified as resistant to meropenem according to the EUCAST breakpoint for this antibiotic, potentially discouraging its use to treat meningitis. All patients were treated with betalactams (ampicillin or amoxicillin), mostly in combination with gentamicin. Treatment outcome was favourable in 15 patients (88.2%). Mortality is known to be high in patients with invasive listeriosis, severe underlying diseases, meningoencephalitis, and inadequate antimicrobial treatment. The early administration of antibiotics, such as ampicillin or cotrimoxazole, which have rapid bactericidal activity against the pathogen, is essential for cure.

The 17 L. monocytogenes clinical isolates included in this study had phenotypic properties consistent with full virulence: β-haemolysis mediated by the product of the listeriolysin gene (hly) and lecithinase activity due to the presence of phospholipases (plcA and plcB). Some differences in growth patterns and invasiveness were observed. Growth pattern (GP) 1 was observed in all but two of the L. monocytogenes isolates (87.5% of all isolates). The L. monocytogenes isolates from cases 6 and 7 (STs 3 and 2) reached the exponential growth phase later than the other isolates (Figure 1). In cell culture assays, invasiveness varied considerably between clinical isolates, with recovery rates ranging from 0.09% to 7.26% (mean 1.62%, standard error 0.46) (Figure 2). The recovery rates for five clinical isolates were reported to range from 4.3% to 30% in a previous study on Vero cells [53]. L. monocytogenes isolates 9, 1, and 8 (all ST1) had the highest levels of virulence in cell culture assays in vitro, as shown by their invasiveness in HeLa cells (invasiveness up to three times that of the wild-type P14 strain). This finding is consistent with those of most previous studies, reporting that lineage I (4b) strains seem to be more virulent and better able to withstand the adverse conditions present in the stomach of the host [19]. ANOVA revealed the existence of two groups of isolates. Group I consisted of six clinical isolates (35.3%) and the wild-type P14 strain, all with significant levels of invasiveness. By contrast, group II contained 11 isolates (64.7%) with nonsignificant levels of invasiveness, similar to that of the isogenic control strain ΔprfA.

In our study of invasive listeriosis cases, the percentage of lineages I and III isolates of L. monocytogenes was similar to that of lineage II isolates (58.8% versus 41.2%, resp.). The isolates responsible for the death of a 68-year-old woman and a foetus were assigned to ST1 and ST389, respectively (lineage I/III, clinical cases 9 and 4). Overall, PFGE identified 14 genotypes and MLST identified 11 genotypes among the 17 L. monocytogenes clinical isolates, yielding values of Simpson’s index of diversity of 0.971 and 0.926, respectively. This indicates a high level of genomic diversity among the clinical isolates (only 55% similarity on PFGE) despite their recovery at the same hospital, consistent with the findings of previous molecular epidemiology studies.

An analysis of the genomic relationships between isolates unequivocally revealed the occurrence of one previously unreported outbreak of listeriosis in humans. This outbreak occurred in October 2009 and affected three patients living in neighbouring towns (clinical cases 8, 9, and 10: pulsotype D, ST1). Isolate 10 had a significantly lower invasion capacity than isolates 8 and 9 (Figure 2), but this difference may simply reflect the method used, with invasion capacity being evaluated in vitro. L. monocytogenes ST1 isolates from Spanish patients are also present in the Pasteur Institute MLST database (2012–2014; Figure 4(a)). Moreover, an epidemiological connection was identified between two isolates from 2006 and 2007, both of which belonged to ST16 and had a PFGE profile I. Data for L. monocytogenes ST16 and ST8 isolates from sporadic clinical cases of human listeriosis are also available from the MLST database (Figure 4(b)). Many previous molecular epidemiology studies have detected otherwise unreported outbreaks of listeriosis. In a recent Spanish study, a large proportion of the clinical isolates had indistinguishable pulsotypes, suggesting the possible occurrence of listeriosis outbreaks related to international foodborne outbreaks. Most of these isolates were assigned to ECI (4b; CC1; 46.2%) and ECIII (1/2a; CC11; 33.3%) [54]. Thus, molecular epidemiology studies of L. monocytogenes can help to identify and trace the sources of outbreaks that would otherwise pass unnoticed.

Interestingly, this is the second time that ST87 has been linked to human disease (it was isolated in León in February 2012). Pérez-Trallero et al. [55] recently reported the occurrence of two outbreaks affecting 15 people and caused by ST87 strains in Guipúzcoa (northern Spain) in 2013 and 2014. Our study demonstrates that ST87 was already circulating in the Spanish clinical environment before the outbreak in Northern Spain. It would be interesting to follow the dissemination of this clone to assess its potential emergence.

In conclusion, this retrospective study focused on invasive L. monocytogenes infections in a Spanish healthcare institution over a nine-year study period. Molecular epidemiology studies clearly revealed the occurrence of a previously unreported outbreak of listeriosis in Northwest Spain. Our findings, along with those of previous studies [5457], indicate that molecular epidemiology studies can help to identify and trace the source of the outbreaks that might otherwise pass unnoticed. Better centralised collection and subtyping of clinical isolates of L. monocytogenes would improve listeriosis monitoring, making it possible to trace the sources of Spanish outbreaks and to prevent cross-border outbreaks.


CAULE:Complejo Asistencial Universitario de León
BHI:Brain heart infusion
MOI:Multiplicity of infection
MLST:Multilocus sequence typing
ST:Sequence type
MST:Minimum spanning tree
CC:Clonal complex
PFGE:Pulsed-field gel electrophoresis
GP:Growth pattern.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This study received support from the Gerencia Regional de Salud, Junta de Castilla y León, Spain, research project GRS 698/A/2011 and the EU 7th Framework Programme through the PROMISE project (Project no. 265877). The authors would like to thank the Pasteur Institute for providing access to the MLST database for L. monocytogenes via the Genotyping of Pathogens and Public Health Platform.


  1. EFSA Panel on Biological Hazards (BIOHAZ), “Scientific opinion on a review on the European Union Summary reports on trends and sources zoonoses, zoonotic agents and food-borne outbreaks in 2009 and 2010—specifically for the data on Salmonella, Campylobacter, verotoxigenic Escherichia coli, Listeria monocytogenes and foodborne outbreaks,” EFSA Journal, vol. 10, no. 6, article 2726, 2012. View at: Publisher Site | Google Scholar
  2. F. Allerberger and M. Wagner, “Listeriosis: a resurgent foodborne infection,” Clinical Microbiology and Infection, vol. 16, no. 1, pp. 16–23, 2010. View at: Publisher Site | Google Scholar
  3. F. Arslan, E. Meynet, M. Sunbul et al., “The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study,” European Journal of Clinical Microbiology and Infectious Diseases, 2015. View at: Publisher Site | Google Scholar
  4. R. Pouillot, K. Hoelzer, K. A. Jackson, O. L. Henao, and B. J. Silk, “Relative risk of listeriosis in foodborne diseases active surveillance network (FoodNet) sites according to age, pregnancy, and ethnicity,” Clinical Infectious Diseases, vol. 54, no. 5, pp. S405–S410, 2012. View at: Publisher Site | Google Scholar
  5. B. J. Silk, K. A. Date, K. A. Jackson et al., “Invasive listeriosis in the foodborne diseases active surveillance network (FoodNet), 2004–2009: further targeted prevention needed for higher-risk groups,” Clinical Infectious Diseases, vol. 54, no. 5, pp. S396–S404, 2012. View at: Publisher Site | Google Scholar
  6. European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), “The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2012,” EFSA Journal, vol. 12, no. 2, article 3547, 312 pages, 2014. View at: Publisher Site | Google Scholar
  7. B. Swaminathan and P. Gerner-Smidt, “The epidemiology of human listeriosis,” Microbes and Infection, vol. 9, no. 10, pp. 1236–1243, 2007. View at: Publisher Site | Google Scholar
  8. S. T. Ooi and B. Lorber, “Gastroenteritis due to Listeria monocytogenes,” Clinical Infectious Diseases, vol. 40, no. 9, pp. 1327–1332, 2005. View at: Publisher Site | Google Scholar
  9. K. Zelenik, J. Avberšek, M. Pate et al., “Cutaneous listeriosis in a veterinarian with the evidence of zoonotic transmission—a case report,” Zoonoses and Public Health, vol. 61, no. 4, pp. 238–241, 2014. View at: Publisher Site | Google Scholar
  10. E. J. Cartwright, K. A. Jackson, S. D. Johnson, L. M. Graves, B. J. Silk, and B. E. Mahon, “Listeriosis outbreaks and associated food vehicles, United States, 1998–2008,” Emerging Infectious Diseases, vol. 19, no. 1, pp. 1–9, 2013. View at: Publisher Site | Google Scholar
  11. R. F. Lamont, J. Sobel, S. Mazaki-Tovi et al., “Listeriosis in human pregnancy: a systematic review,” Journal of Perinatal Medicine, vol. 39, no. 3, pp. 227–236, 2011. View at: Publisher Site | Google Scholar
  12. J. A. Painter, R. M. Hoekstra, T. Ayers et al., “Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998–2008,” Emerging Infectious Diseases, vol. 19, article 407, 2013. View at: Publisher Site | Google Scholar
  13. D. Liu, “Identification, subtyping and virulence determination of Listeria monocytogenes, an important foodborne pathogen,” Journal of Medical Microbiology, vol. 55, no. 6, pp. 645–659, 2006. View at: Publisher Site | Google Scholar
  14. R. H. Orsi, H. C. den Bakker, and M. Wiedmann, “Listeria monocytogenes lineages: genomics, evolution, ecology, and phenotypic characteristics,” International Journal of Medical Microbiology, vol. 301, no. 2, pp. 79–96, 2011. View at: Publisher Site | Google Scholar
  15. S. Kathariou, “Listeria monocytogenes virulence and pathogenicity, a food safety perspective,” Journal of Food Protection, vol. 65, no. 11, pp. 1811–1829, 2002. View at: Google Scholar
  16. T. Cantinelli, V. Chenal-Francisque, L. Diancourt et al., “‘Epidemic clones’ of Listeria monocytogenes are widespread and ancient clonal groups,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3770–3779, 2013. View at: Publisher Site | Google Scholar
  17. M. Ragon, T. Wirth, F. Hollandt et al., “A new perspective on Listeria monocytogenes evolution,” PLoS Pathogens, vol. 4, no. 9, Article ID e1000146, 2008. View at: Publisher Site | Google Scholar
  18. V. Chenal-Francisque, J. Lopez, T. Cantinelli et al., “World wide distribution of major clones of Listeria monocytogenes,” Emerging Infectious Diseases, vol. 17, no. 6, pp. 1110–1112, 2011. View at: Publisher Site | Google Scholar
  19. J. Chen, X. Luo, L. Jiang et al., “Molecular characteristics and virulence potential of Listeria monocytogenes isolates from Chinese food systems,” Food Microbiology, vol. 26, no. 1, pp. 103–111, 2009. View at: Publisher Site | Google Scholar
  20. S. Lomonaco, B. Verghese, P. Gerner-Smidt et al., “Novel epidemic clones of Listeria monocytogenes, United States, 2011,” Emerging Infectious Diseases, vol. 19, no. 1, pp. 147–150, 2013. View at: Publisher Site | Google Scholar
  21. M. M. Koopmans, M. C. Brouwer, M. W. Bijlsma et al., “Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study,” Clinical Infectious Diseases, vol. 57, no. 2, pp. 247–253, 2013. View at: Publisher Site | Google Scholar
  22. D. Althaus, A. Lehner, S. Brisse, M. Maury, T. Tasara, and R. Stephan, “Characterization of Listeria monocytogenes strains isolated during 2011–2013 from human infections in Switzerland,” Foodborne Pathogens and Disease, vol. 11, no. 10, pp. 753–758, 2014. View at: Publisher Site | Google Scholar
  23. M. A. De Francesco, S. Corbellini, G. Piccinelli et al., “A cluster of invasive listeriosis in Brescia, Italy,” Infection, vol. 43, no. 3, pp. 379–382, 2015. View at: Publisher Site | Google Scholar
  24. C. Mammina, A. Parisi, A. Guaita et al., “Enhanced surveillance of invasive listeriosis in the Lombardy region, Italy, in the years 2006–2010 reveals major clones and an increase in serotype 1/2a,” BMC Infectious Diseases, vol. 13, no. 1, article 152, 2013. View at: Publisher Site | Google Scholar
  25. E. Doménech, A. Jimenez-Belenguer, J. A. Amoros, M. A. Ferrus, and I. Escriche, “Prevalence and antimicrobial resistance of Listeria monocytogenes and Salmonella strains isolated in ready-to-eat foods in Eastern Spain,” Food Control, vol. 47, pp. 120–125, 2015. View at: Publisher Site | Google Scholar
  26. S. T. Lambertz, S. Ivarsson, G. Lopez-Valladares, M. Sidstedt, and R. Lindqvist, “Subtyping of Listeria monocytogenes isolates recovered from retail ready-to-eat foods, processing plants and listeriosis patients in Sweden 2010,” International Journal of Food Microbiology, vol. 166, no. 1, pp. 186–192, 2013. View at: Publisher Site | Google Scholar
  27. G. Lopez-Valladares, W. Tham, V. S. Parihar et al., “Human isolates of Listeria monocytogenes in Sweden during half a century (1958–2010),” Epidemiology & Infection, vol. 142, no. 11, pp. 2251–2260, 2014. View at: Publisher Site | Google Scholar
  28. B. T. Lunestad, T. T. T. Truong, and B.-A. Lindstedt, “A multiple-locus variable-number tandem repeat analysis (MLVA) of Listeria monocytogenes isolated from Norwegian salmon-processing factories and from listeriosis patients,” Epidemiology and Infection, vol. 141, no. 10, pp. 2101–2110, 2013. View at: Publisher Site | Google Scholar
  29. U. M. Nakari, L. Rantala, A. Pihlajasaari et al., “Investigation of increased listeriosis revealed two fishery production plants with persistent Listeria contamination in Finland in 2010,” Epidemiology & Infection, vol. 142, no. 11, pp. 2261–2269, 2014. View at: Publisher Site | Google Scholar
  30. V. De Castro, J. Escudero, J. Rodriguez et al., “Listeriosis outbreak caused by Latin-style fresh cheese, Bizkaia, Spain, August 2012,” Euro Surveillance, vol. 17, no. 42, p. 20298, 2012. View at: Google Scholar
  31. S. J. Knabel, A. Reimer, B. Verghese et al., “Sequence typing confirms that a predominant Listeria monocytogenes clone caused human listeriosis cases and outbreaks in Canada from 1988 to 2010,” Journal of Clinical Microbiology, vol. 50, no. 5, pp. 1748–1751, 2012. View at: Publisher Site | Google Scholar
  32. D. Schoder, B. Stessl, K. Szakmary-Brändle, P. Rossmanith, and M. Wagner, “Population diversity of Listeria monocytogenes in quargel (acid curd cheese) lots recalled during the multinational listeriosis outbreak 2009/2010,” Food Microbiology, vol. 39, pp. 68–73, 2014. View at: Publisher Site | Google Scholar
  33. B. Stessl, M. Fricker, E. Fox et al., “Collaborative survey on the colonization of different types of cheese-processing facilities with Listeria monocytogenes,” Foodborne Pathogens and Disease, vol. 11, no. 1, pp. 8–14, 2014. View at: Publisher Site | Google Scholar
  34. F. P. Valero and J. V. Rafart, “Incidence study of listeriosis in Spain,” Gaceta Sanitaria, vol. 28, no. 1, pp. 74–76, 2014. View at: Publisher Site | Google Scholar
  35. M. O. Martínez, R. J. Colomina, M. M. Domínguez, E. A. Guerrero, and A. A. de la Encarnación, “Invasive listeriosis in Valencian community, Spain, during the period 2008–2010,” Revista Espanola de Salud Publica, vol. 86, pp. 645–651, 2012. View at: Google Scholar
  36. D. Rodríguez-Lázaro, M. Hernández, and M. Pla, “Simultaneous quantitative detection of Listeria spp. and Listeria monocytogenes using a duplex real-time PCR-based assay,” FEMS Microbiology Letters, vol. 233, no. 2, pp. 257–267, 2004. View at: Publisher Site | Google Scholar
  37. D. Rodríguez-Lázaro, M. Hernández, M. Scortti, T. Esteve, J. A. Vázquez-Boland, and M. Pla, “Quantitative detection of Listeria monocytogenes and Listeria innocua by real-time PCR: assessment of hly, iap, and lin02483 targets and AmpliFluor technology,” Applied and Environmental Microbiology, vol. 70, no. 3, pp. 1366–1377, 2004. View at: Publisher Site | Google Scholar
  38. D. Rodríguez-Lázaro, L. López-Enríquez, and M. Hernández, “SmcL as a novel diagnostic marker for quantitative detection of Listeria ivanovii in biological samples,” Journal of Applied Microbiology, vol. 109, no. 3, pp. 863–872, 2010. View at: Publisher Site | Google Scholar
  39. D. Rodríguez-Lázaro, M. Pla, M. Scortti, H. J. Monzó, and J. A. Vázquez-Boland, “A novel real-time PCR for Listeria monocytogenes that monitors analytical performance via an internal amplification control,” Applied and Environmental Microbiology, vol. 71, no. 12, pp. 9008–9012, 2005. View at: Publisher Site | Google Scholar
  40. European Committee on Antimicrobial Susceptibility Testing, Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 5.0, 2015.
  41. M. Suárez, B. González-Zorn, Y. Vega, I. Chico-Calero, and J.-A. Vázquez-Boland, “A role for ActA in epithelial cell invasion by Listeria monocytogenes,” Cellular Microbiology, vol. 3, no. 12, pp. 853–864, 2001. View at: Publisher Site | Google Scholar
  42. M. Doumith, C. Buchrieser, P. Glaser, C. Jacquet, and P. Martin, “Differentiation of the major Listeria monocytogenes serovars by multiplex PCR,” Journal of Clinical Microbiology, vol. 42, no. 8, pp. 3819–3822, 2004. View at: Publisher Site | Google Scholar
  43. A. Leclercq, V. Chenal-Francisque, H. Dieye et al., “Characterization of the novel Listeria monocytogenes PCR serogrouping profile IVb-v1,” International Journal of Food Microbiology, vol. 147, no. 1, pp. 74–77, 2011. View at: Publisher Site | Google Scholar
  44. L. M. Graves and B. Swaminathan, “PulseNet standardized protocol for subtyping Listeria monocytogenes by macrorestriction and pulsed-field gel electrophoresis,” International Journal of Food Microbiology, vol. 65, no. 1-2, pp. 55–62, 2001. View at: Publisher Site | Google Scholar
  45. P. Martin, C. Jacquet, V. Goulet, V. Vaillant, and H. De Valk, “Pulsed-field gel electrophoresis of Listeria monocytogenes strains: the PulseNet Europe Feasibility Study,” Foodborne Pathogens and Disease, vol. 3, no. 3, pp. 303–308, 2006. View at: Google Scholar
  46. P. R. Hunter and M. A. Gaston, “Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity,” Journal of Clinical Microbiology, vol. 26, no. 11, pp. 2465–2466, 1988. View at: Google Scholar
  47. Comparing partitions online tool, 2013,
  48. T. J. Barrett, P. Gerner-Smidt, and B. Swaminathan, “Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance,” Foodborne Pathogens and Disease, vol. 3, no. 1, pp. 20–31, 2006. View at: Publisher Site | Google Scholar
  49. Institut Pasteur, “Listeria monocytogenes MLST database,” 2015, View at: Google Scholar
  50. C. M. De Noordhout, B. Devleesschauwer, F. J. Angulo et al., “The global burden of listeriosis: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 14, no. 11, pp. 1073–1082, 2014. View at: Publisher Site | Google Scholar
  51. F. Marco, “In vitro activities of 22 antimicrobial agents against Listeria monocytogenes strains isolated in Barcelona, Spain,” Diagnostic Microbiology and Infectious Disease, vol. 38, no. 4, pp. 259–261, 2000. View at: Publisher Site | Google Scholar
  52. A. Alonso-Hernando, M. Prieto, C. García-Fernández, C. Alonso-Calleja, and R. Capita, “Increase over time in the prevalence of multiple antibiotic resistance among isolates of Listeria monocytogenes from poultry in Spain,” Food Control, vol. 23, no. 1, pp. 37–41, 2012. View at: Publisher Site | Google Scholar
  53. F. Yamada, F. Ueda, Y. Ochiai et al., “Invasion assay of Listeria monocytogenes using Vero and Caco-2 cells,” Journal of Microbiological Methods, vol. 66, no. 1, pp. 96–103, 2006. View at: Publisher Site | Google Scholar
  54. J. A. Lepe, M. J. Torres, J. Liró, R. Luque, and J. Aznar, “Microbiological characterisation of Listeria monocytogenes isolates from human cases in Andalusia,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 30, no. 10, pp. 602–607, 2012. View at: Publisher Site | Google Scholar
  55. E. Pérez-Trallero, C. Zigorraga, J. Artieda, M. Alkorta, and J. M. Marimón, “Two outbreaks of Listeria monocytogenes infection, Northern Spain,” Emerging Infectious Diseases, vol. 20, no. 12, pp. 2155–2157, 2014. View at: Publisher Site | Google Scholar
  56. R. Magalhães, G. Almeida, V. Ferreira et al., “Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012,” Eurosurveillance, vol. 20, no. 17, p. 21104, 2015, to. View at: Google Scholar
  57. D. Montero, M. Bodero, G. Riveros et al., “Molecular epidemiology and genetic diversity of Listeria monocytogenes isolates from a wide variety of ready-to-eat foods and their relationship to clinical strains from listeriosis outbreaks in Chile,” Frontiers in Microbiology, vol. 6, article 384, 2015. View at: Publisher Site | Google Scholar

Copyright © 2015 Jaime Ariza-Miguel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.